Akoya Biosciences Inc logo

AKYA

Akoya Biosciences Inc

$13.17

Earnings Summary

Revenue
$16.89Mn
Net Profits
$-16.4Mn
Net Profit Margins
-97.07%

Highlights

Revenue:

Akoya Biosciences Inc’s revenue jumped 38.34% since last year same period to $16.89Mn in the Q1 2022. On a quarterly growth basis, Akoya Biosciences Inc has generated 262.61% jump in its revenue since last 3-months.

Net Profits:

Akoya Biosciences Inc’s net profit fell -102.91% since last year same period to $-16.4Mn in the Q1 2022. On a quarterly growth basis, Akoya Biosciences Inc has generated 7.21% jump in its net profits since last 3-months.

Net Profit Margins:

Akoya Biosciences Inc’s net profit margin fell -46.67% since last year same period to -97.07% in the Q1 2022. On a quarterly growth basis, Akoya Biosciences Inc has generated -157.06% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Akoya Biosciences Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.37
EPS Estimate Current Year
-0.37

Highlights

EPS Estimate Current Quarter:

Akoya Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.37 - a 5.13% jump from last quarter’s estimates.

EPS Estimate Current Year:

Akoya Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.37.

Key Ratios

Key ratios of the Akoya Biosciences Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.44
Return on Assets (ROA)
-0.19
Return on Equity (ROE)
-0.53
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Akoya Biosciences Inc’s earning per share (EPS) jumped 87.57% since last year same period to -0.44 in the Q1 2022. This indicates that the Akoya Biosciences Inc has generated 87.57% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Akoya Biosciences Inc’s return on assets (ROA) stands at -0.19.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Akoya Biosciences Inc’s return on equity (ROE) stands at -0.53.

Dividend Per Share (DPS):

Akoya Biosciences Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-06
-0.39
-0.44
-12.82%

Company Information

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.

Organisation
Akoya Biosciences Inc
Employees
169